Biomarin Pharmaceutical IncNASDAQ:BMRN
- LAST PRICE115.3500
- TODAY'S CHANGE (%)0.6500 (0.5667%)
- Bid / Lots114.5200/ 1
- Ask / Lots115.6300/ 1
- Open / Previous Close115.0000 / 114.7000
- Day Range
- 52 Week Range
- Volume1,237,395
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BMRN |
|---|---|---|
| 09:32 ET | 9517 | 114.89 |
| 09:33 ET | 16406 | 115.24 |
| 09:35 ET | 6060 | 115.32 |
| 09:37 ET | 1900 | 114.965 |
| 09:39 ET | 11700 | 114.965 |
| 09:42 ET | 1634 | 115.125 |
| 09:44 ET | 2200 | 114.97 |
| 09:46 ET | 2710 | 114.995 |
| 09:48 ET | 1900 | 115.11 |
| 09:50 ET | 500 | 115.1 |
| 09:53 ET | 1214 | 115.2 |
| 09:55 ET | 1900 | 115.17 |
| 09:57 ET | 400 | 115.18 |
| 10:00 ET | 6527 | 115.37 |
| 10:02 ET | 1400 | 115.43 |
| 10:04 ET | 1601 | 115.42 |
| 10:06 ET | 1296 | 115.07 |
| 10:08 ET | 1600 | 115.095 |
| 10:09 ET | 2150 | 115.165 |
| 10:11 ET | 1300 | 115.27 |
| 10:13 ET | 8715 | 115.21 |
| 10:15 ET | 342 | 115.3215 |
| 10:18 ET | 1594 | 115.288 |
| 10:20 ET | 6811 | 115.46 |
| 10:22 ET | 1775 | 115.34 |
| 10:24 ET | 5407 | 115.32 |
| 10:26 ET | 400 | 115.295 |
| 10:27 ET | 1447 | 115.03 |
| 10:29 ET | 4260 | 115.02 |
| 10:31 ET | 200 | 115.025 |
| 10:33 ET | 300 | 115.12 |
| 10:36 ET | 700 | 115.17 |
| 10:38 ET | 4100 | 115.36 |
| 10:40 ET | 1700 | 115.32 |
| 10:42 ET | 900 | 115.51 |
| 10:44 ET | 1121 | 115.455 |
| 10:45 ET | 931 | 115.59 |
| 10:47 ET | 1910 | 115.48 |
| 10:49 ET | 400 | 115.49 |
| 10:51 ET | 400 | 115.4 |
| 10:54 ET | 100 | 115.35 |
| 10:56 ET | 1237 | 115.285 |
| 10:58 ET | 2300 | 115.4 |
| 11:00 ET | 1845 | 115.35 |
| 11:02 ET | 1194 | 115.43 |
| 11:03 ET | 1168 | 115.46 |
| 11:05 ET | 503 | 115.46 |
| 11:07 ET | 200 | 115.475 |
| 11:09 ET | 1300 | 115.42 |
| 11:12 ET | 2660 | 115.44 |
| 11:14 ET | 3300 | 115.435 |
| 11:16 ET | 9700 | 115.28 |
| 11:18 ET | 3674 | 115.385 |
| 11:20 ET | 2400 | 115.45 |
| 11:21 ET | 547 | 115.47 |
| 11:23 ET | 6196 | 115.41 |
| 11:25 ET | 4068 | 115.42 |
| 11:27 ET | 1300 | 115.445 |
| 11:30 ET | 2200 | 115.505 |
| 11:32 ET | 100 | 115.49 |
| 11:34 ET | 1100 | 115.49 |
| 11:36 ET | 1161 | 115.4473 |
| 11:38 ET | 533 | 115.4 |
| 11:39 ET | 800 | 115.265 |
| 11:41 ET | 11853 | 115.245 |
| 11:43 ET | 40095 | 115.185 |
| 11:45 ET | 3912 | 115.25 |
| 11:48 ET | 11733 | 115.09 |
| 11:50 ET | 4515 | 114.94 |
| 11:52 ET | 13507 | 114.9 |
| 11:54 ET | 4230 | 115.055 |
| 11:56 ET | 2008 | 114.91 |
| 11:57 ET | 500 | 114.77 |
| 11:59 ET | 500 | 114.745 |
| 12:01 ET | 1690 | 114.71 |
| 12:03 ET | 1783 | 114.65 |
| 12:06 ET | 600 | 114.68 |
| 12:08 ET | 800 | 114.605 |
| 12:10 ET | 3611 | 114.73 |
| 12:12 ET | 4609 | 114.8 |
| 12:14 ET | 3100 | 114.71 |
| 12:15 ET | 2536 | 114.75 |
| 12:17 ET | 400 | 114.73 |
| 12:19 ET | 2818 | 114.84 |
| 12:21 ET | 1500 | 114.815 |
| 12:24 ET | 3161 | 114.795 |
| 12:26 ET | 2532 | 114.92 |
| 12:28 ET | 4309 | 114.8 |
| 12:30 ET | 2733 | 114.95 |
| 12:32 ET | 800 | 115.04 |
| 12:33 ET | 726 | 115 |
| 12:35 ET | 3215 | 114.89 |
| 12:37 ET | 1635 | 114.945 |
| 12:39 ET | 973 | 114.885 |
| 12:42 ET | 2050 | 114.98 |
| 12:44 ET | 850 | 114.915 |
| 12:46 ET | 4490 | 114.965 |
| 12:48 ET | 6136 | 114.92 |
| 12:50 ET | 2556 | 114.96 |
| 12:51 ET | 500 | 114.95 |
| 12:53 ET | 1973 | 114.935 |
| 12:55 ET | 1100 | 114.97 |
| 12:57 ET | 3132 | 115.02 |
| 01:00 ET | 2551 | 114.95 |
| 01:02 ET | 2653 | 114.925 |
| 01:04 ET | 694 | 114.96 |
| 01:06 ET | 900 | 114.98 |
| 01:08 ET | 2900 | 114.95 |
| 01:09 ET | 1725 | 115.01 |
| 01:11 ET | 400 | 114.971 |
| 01:13 ET | 1544 | 114.845 |
| 01:15 ET | 1800 | 114.9 |
| 01:18 ET | 100 | 114.87 |
| 01:20 ET | 1100 | 114.89 |
| 01:22 ET | 367 | 114.91 |
| 01:24 ET | 1600 | 114.72 |
| 01:26 ET | 500 | 114.75 |
| 01:27 ET | 4381 | 114.82 |
| 01:29 ET | 1300 | 114.97 |
| 01:31 ET | 4824 | 114.975 |
| 01:33 ET | 1878 | 114.885 |
| 01:36 ET | 800 | 114.955 |
| 01:38 ET | 200 | 114.93 |
| 01:40 ET | 1000 | 115.02 |
| 01:42 ET | 2320 | 115 |
| 01:44 ET | 700 | 114.98 |
| 01:45 ET | 2000 | 114.98 |
| 01:47 ET | 3410 | 114.9 |
| 01:49 ET | 800 | 114.94 |
| 01:51 ET | 400 | 114.94 |
| 01:54 ET | 800 | 114.93 |
| 01:56 ET | 1300 | 114.94 |
| 01:58 ET | 3124 | 114.95 |
| 02:00 ET | 2813 | 114.98 |
| 02:02 ET | 3150 | 114.92 |
| 02:03 ET | 700 | 114.935 |
| 02:05 ET | 200 | 114.935 |
| 02:07 ET | 400 | 114.95 |
| 02:09 ET | 1375 | 114.93 |
| 02:12 ET | 400 | 114.94 |
| 02:14 ET | 952 | 114.91 |
| 02:16 ET | 3947 | 114.79 |
| 02:18 ET | 2906 | 114.85 |
| 02:20 ET | 4200 | 114.88 |
| 02:21 ET | 1000 | 114.89 |
| 02:23 ET | 1449 | 114.89 |
| 02:25 ET | 2910 | 114.9 |
| 02:27 ET | 400 | 114.88 |
| 02:30 ET | 1798 | 114.895 |
| 02:32 ET | 900 | 114.895 |
| 02:34 ET | 2500 | 114.79 |
| 02:36 ET | 1349 | 114.85 |
| 02:38 ET | 1505 | 114.86 |
| 02:39 ET | 1000 | 114.88 |
| 02:41 ET | 1050 | 114.88 |
| 02:43 ET | 761 | 114.9 |
| 02:45 ET | 1600 | 114.88 |
| 02:48 ET | 1232 | 114.87 |
| 02:50 ET | 850 | 114.82 |
| 02:52 ET | 4604 | 114.9 |
| 02:54 ET | 700 | 114.9 |
| 02:56 ET | 1700 | 114.89 |
| 02:57 ET | 1000 | 114.85 |
| 02:59 ET | 2218 | 114.89 |
| 03:01 ET | 2000 | 114.88 |
| 03:03 ET | 2839 | 114.86 |
| 03:06 ET | 13295 | 114.89 |
| 03:08 ET | 1900 | 114.89 |
| 03:10 ET | 1059 | 114.925 |
| 03:12 ET | 3590 | 114.9049 |
| 03:14 ET | 2210 | 114.875 |
| 03:15 ET | 2736 | 114.96 |
| 03:17 ET | 8865 | 114.98 |
| 03:19 ET | 2422 | 115.015 |
| 03:21 ET | 5444 | 115.01 |
| 03:24 ET | 3149 | 115.01 |
| 03:26 ET | 2525 | 114.99 |
| 03:28 ET | 700 | 115 |
| 03:30 ET | 7408 | 114.88 |
| 03:32 ET | 1100 | 114.63 |
| 03:33 ET | 4524 | 114.72 |
| 03:35 ET | 1677 | 114.87 |
| 03:37 ET | 1724 | 114.92 |
| 03:39 ET | 3174 | 114.94 |
| 03:42 ET | 3707 | 115 |
| 03:44 ET | 2900 | 114.79 |
| 03:46 ET | 1000 | 114.75 |
| 03:48 ET | 5239 | 114.84 |
| 03:50 ET | 4609 | 114.88 |
| 03:51 ET | 11106 | 114.93 |
| 03:53 ET | 5218 | 114.905 |
| 03:55 ET | 19946 | 115.12 |
| 03:57 ET | 16471 | 115.26 |
| 04:00 ET | 17540 | 115.35 |
Yesterday
BMO Capital Initiates BioMarin Pharmaceutical at Market Perform With $107 Price Target, from 7:05AM ET on Monday Jan 30, 2023 by MT Newswires
7:05AM ET on Monday Jan 30, 2023 by MT Newswires
Jan 24, 2023
Morgan Stanley Raises Price Target on BioMarin Pharmaceutical to $132 From $113, Maintains Overweight Rating, from 9:25AM ET on Tuesday Jan 24, 2023 by MT Newswires
9:25AM ET on Tuesday Jan 24, 2023 by MT Newswires
Jan 19, 2023
Insider Sell: Biomarin Pharmaceutical, from 1:25AM ET on Thursday Jan 19, 2023 by MT Newswires
1:25AM ET on Thursday Jan 19, 2023 by MT Newswires
Jan 11, 2023
Wedbush Raises BioMarin Pharmaceutical's Price Target to $83 From $74 After Model Adjustments, Keeps Neutral Rating, from 7:42AM ET on Wednesday Jan 11, 2023 by MT Newswires
7:42AM ET on Wednesday Jan 11, 2023 by MT Newswires
Jan 8, 2023
BRIEF-Biomarin Announces Stable And Durable Annualized Bleed Control For Roctavian In Phase 3 Gene Therapy Study In Adults With Severe Hemophilia, from 11:02AM ET on Sunday Jan 08, 2023 by Thomson Reuters
11:02AM ET on Sunday Jan 08, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biomarin Pharmaceutical Inc | 21.3B | 292.2x | --- |
argenx SE | 20.9B | -21.9x | --- |
Seagen Inc | 26.0B | -40.3x | --- |
Beigene Ltd | 27.3B | -12.0x | --- |
Exact Sciences Corp | 11.8B | -16.5x | --- |
United Therapeutics Corp | 11.8B | 17.9x | -7.98% |
Company Information
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company that develops and commercializes therapies. The Company's portfolio consists of seven commercial products and multiple clinical and preclinical product candidates for the treatment of various diseases. BioMarin 's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Kuvan (sapropterin dihydrochloride), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa) and Voxzogo (vosoritide). BioMarin's clinical development programs include Valoctocogene roxaparvovec is an adeno associated virus (AAV5) vector drug development candidate designed to restore factor VIII plasma concentrations in patients with severe hemophilia A; BMN 307 is an AAV5 mediated gene therapy that is designed to normalize blood Phe concentration levels in patients with Phenylketonuria (PKU), and BMN 255 is a small-molecule therapy that is designed to treat primary hyperoxaluria type 1, a subset of chronic renal disease.
Contact Information
- Headquarters
- 105 Digital DrNOVATO, CA, United States 94949-8703
- Phone
- 415-506-6700
- Fax
- 415-382-7889
Executives
- Chairman of the Board, Chief Executive Officer
- Jean-Jacques Bienaime
- Chief Financial Officer, Executive Vice President - Finance
- Brian Mueller
- President - Worldwide Research and Development
- Henry Fuchs
- Executive Vice President - Global Manufacturing and Technical Operations, Chief Technical Officer
- C. Greg Guyer
- Executive Vice President, General Counsel, Secretary
- G. Eric Davis
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $21.3B |
|---|---|
Revenue (TTM) | $2.0B |
Shares Outstanding | 185.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $0.39 |
Book Value | $23.22 |
P/E Ratio | 292.2x |
Price/Sales (TTM) | 10.6 |
Price/Cash Flow (TTM) | 116.2x |
Operating Margin | 5.39% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
